Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients.

International journal of cancer - 15 Aug 2001

Zia A, Schildberg F W, Funke I

Abstract excerpt

Changing the major histocompatibility complex (MHC) class I phenotype is a pivotal strategy of tumor cells to circumvent an effective immune response and is associated with tumor progression in cancer patients. Epithelial cells in bone marrow have been detected in various tumor types, but the clinical observation that only a portion of the patients with a positive bone marrow status develops solid bone metastasis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Down-Regulation
Share to Epithelial Cells

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class I

Share to HLA Antigens

Share to Keratins

Share to Neoplasm, Residual

Share to Survival Rate

Source

Identifiers

PMID: 11477561
DOI: 10.1002/ijc.1362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients.PMID 11477561Read ↗

Cancer immune escape: MHC expression in primary tumours versus metastasesSemantic proximity Read ↗

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.Semantic proximity Read ↗

Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients.Semantic proximity Read ↗

Altered MHC class I antigens in tumors.Semantic proximity Read ↗

Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.Semantic proximity Read ↗

MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.Semantic proximity Read ↗

The biological consequences of altered MHC class I expression in tumours.Semantic proximity Read ↗

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.Semantic proximity Read ↗

Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.Semantic proximity Read ↗

Cytokeratin 8-MHC class I interactions: A potential novel immune escape phenotype by a lymph node metastatic carcinoma cell lineSemantic proximity Read ↗

Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective.Semantic proximity Read ↗

Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.